MedPath
HSA Approval

DBL Magnesium Sulfate Concentrated Injection 49.3%

SIN05860P

DBL Magnesium Sulfate Concentrated Injection 49.3%

DBL Magnesium Sulfate Concentrated Injection 49.3%

May 21, 1991

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

B05XA05

magnesium sulfate

Manufacturer Information

PFIZER PRIVATE LIMITED

Siegfried Hameln GmbH

Active Ingredients

MAGNESIUM SULPHATE

2.47 g/5 ml

Magnesium sulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL Magnesium Sulfate Concentrated Injection 49.3% - HSA Approval | MedPath